Bora Lim

The University of Texas MD Anderson Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

4.9Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A spatially resolved single-cell genomic atlas of the adult human breast

Nature(2023)10.1038/s41586-023-06252-9

Top 6%

3.8DataRank

Top 6%241 citations

Kevin Nee, Runmin Wei, Siyuan He, Quy Nguyen, Shanshan Bai +35 more

Papers

Driven by 40 papers — median percentile 82. Top paper: “A spatially resolved single-cell genomic atlas of the adult human breast”.

A spatially resolved single-cell genomic atlas of the adult human breast

Nature(2023)10.1038/s41586-023-06252-9

Top 6%

3.8DataRank

Top 6%241 citations

Kevin Nee, Runmin Wei, Siyuan He, Quy Nguyen, Shanshan Bai +35 more

Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer

Cancer Discovery(2022)10.1158/2159-8290.cd-22-0200

N/A

2.5DataRank · unranked

140 citations

Eric J. Jaehnig, Karsten Krug, Jonathan T. Lei, Erik J. Bergstrom, Beom-Jun Kim +34 more

Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0144

N/A

2.0DataRank · unranked

79 citations

Er-Yen Yen, Jeffrey T. Chang, Roland L. Bassett, Gheath Alatrash, Haven R. Garber +26 more

Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3100

N/A

1.3DataRank · unranked

42 citations

Nour Abuhadra, Ryan Sun, Beatriz E. Adrada, Qingqing Ding, Jason B. White +22 more

A spatially resolved single cell genomic atlas of the adult human breast

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.22.537946

Top 18%

1.1DataRank

Top 18%27 citations

Kevin Nee, Runmin Wei, Siyuan He, Quy Nguyen, Shanshan Bai +32 more

Molecular mechanisms of snoRNA-IL-15 crosstalk in adipocyte lipolysis and NK cell rejuvenation

Cell Metabolism(2023)10.1016/j.cmet.2023.05.009

N/A

0.787DataRank · unranked

24 citations

Zilong Zhao, Lisa A. Huang, Yuan Liu, Jun Yao, Cheng‐Cao Sun +23 more

Solid tumour-induced systemic immunosuppression involves dichotomous myeloid–B cell interactions

Nature Cell Biology(2024)10.1038/s41556-024-01508-6

N/A

0.425DataRank · unranked

16 citations

Yichao Shen, Jun Liu, Angela Alexander, Ling Wu, Zhan Xu +14 more

Targeting chemotherapy resistance in mesenchymal triple-negative breast cancer: a phase II trial of neoadjuvant angiogenic and mTOR inhibition with chemotherapy

Investigational New Drugs(2023)10.1007/s10637-023-01357-4

N/A

0.285DataRank · unranked

5 citations

Ryan Sun, Roland L. Bassett, Lei Huo, Jeffrey T. Chang, Mediget Teshome +24 more

Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs

Cancers(2025)10.3390/cancers17111852

N/A

0.176DataRank · unranked

2 citations

Faiyaz Rahman, Bahriye Karakaş, Muhammad Daniel Abdul Shahid, Bora Lim, Stephanie J. Bouley +6 more

Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review

PLoS ONE(2021)10.1371/journal.pone.0250057

N/A

0DataRank · unranked

9 citations

José Rodrigo Espinosa Fernández, James P. Long, Toshiaki Iwase, Kumiko Kida, Xiaoping Wang +5 more

Tumor cell total mRNA expression shapes the molecular and clinical phenotype of cancer

Research Square(2021)10.21203/rs.3.rs-600171/v1

N/A

0DataRank · unranked

2 citations

Jennifer Wang, Shuangxi Ji, Yang Peng, Matthew D. Montierth, Shuai Guo +32 more

Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy

Nature Communications(2022)10.1038/s41467-022-29539-3

N/A

0DataRank · unranked

117 citations

Yanshuo Chu, Mercy Misoi, María E. Suarez‐Almazor, Jean Tayar, Huifang Lu +33 more

Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression

Nature Biotechnology(2022)10.1038/s41587-022-01342-x

N/A

0DataRank · unranked

76 citations

Jennifer Wang, Shuangxi Ji, Yang Peng, Yaoyi Dai, Shuai Guo +35 more

Hormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditis

Science Translational Medicine(2022)10.1126/scitranslmed.abo1981

N/A

0DataRank · unranked

57 citations

Cheng‐Cao Sun, Yajuan Li, Juan Qin, Kaushik Amancherla, Ying Jing +26 more

Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Frontiers in Artificial Intelligence(2022)10.3389/frai.2022.876100

N/A

0DataRank · unranked

21 citations

Ranran Wu, Jody V. Vykoukal, Eunice Murage, Rachelle Spencer, Jennifer B. Dennison +18 more

Poziotinib Inhibits HER2-Mutant–Driven Therapeutic Resistance and Multiorgan Metastasis in Breast Cancer

Cancer Research(2022)10.1158/0008-5472.can-21-3106

N/A

0DataRank · unranked

17 citations

Ching Hui Chen, Junkai Wang, Ahmad Bin Salam, Lacey E. Dobrolecki, Alaina Lewis +9 more

BET inhibition induces vulnerability to MCL1 targeting through upregulation of fatty acid synthesis pathway in breast cancer

Cell Reports(2022)10.1016/j.celrep.2022.111304

N/A

0DataRank · unranked

8 citations

Augustin Luna, Heping Wang, Behnaz Bozorgui, Xubin Li, Maga Sanchez +16 more

Advancing Cancer Research and Medicine with Single-Cell Genomics

Cancer Cell(2020)10.1016/j.ccell.2020.03.008

N/A

0DataRank · unranked

332 citations

Yiyun Lin, Nicholas E. Navin, Bora Lim

Mitochondrial structure and function adaptation in residual triple negative breast cancer cells surviving chemotherapy treatment

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.25.481996

N/A

0DataRank · unranked

6 citations

Junegoo Lee, Katherine E. Pendleton, Mariah J. Berner, Emily Goff, Lin Tan +9 more

Mitochondrial structure and function adaptation in residual triple negative breast cancer cells surviving chemotherapy treatment

Oncogene(2023)10.1038/s41388-023-02596-8

N/A

0DataRank · unranked

80 citations

Junegoo Lee, Katherine E. Pendleton, Mariah J. Berner, Emily Goff, Lin Tan +10 more

Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal

Cell stem cell(2023)10.1016/j.stem.2023.04.005

N/A

0DataRank · unranked

60 citations

Yichao Shen, Nan Chen, Weijie Zhang, Elizabeth Valverde, Ling Wu +25 more

Ultralow-dose binary oncolytic/helper-dependent adenovirus promotes antitumor activity in preclinical and clinical studies

Science Advances(2023)10.1126/sciadv.ade6790

N/A

0DataRank · unranked

28 citations

Caroline E. Porter, Bora Lim, Amanda Rosewell Shaw, Catherine Robertson, Mae Woods +9 more

Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor–positive Breast Cancers for Targeted Treatment

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0044

N/A

0DataRank · unranked

8 citations

Ze-Yi Zheng, Jonathan T. Lei, Matthew V. Holt, Anran Chen, Jianheng Peng +20 more

Data from Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6530597

N/A

0DataRank · unranked

0 citations

Er-Yen Yen, Jeffrey T. Chang, Roland L. Bassett, Gheath Alatrash, Haven R. Garber +26 more

Data from Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6532592

Top 100%

0DataRank

Top 100%0 citations

Nour Abuhadra, Ryan Sun, Beatriz E. Adrada, Qingqing Ding, Jason B. White +22 more

Data from Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6530597.v1

N/A

0DataRank · unranked

0 citations

Er-Yen Yen, Jeffrey T. Chang, Roland L. Bassett, Gheath Alatrash, Haven R. Garber +26 more

Data from Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor–positive Breast Cancers for Targeted Treatment

(2023)10.1158/2767-9764.c.6729507.v2

N/A

0DataRank · unranked

0 citations

Ze-Yi Zheng, Jonathan T. Lei, Matthew V. Holt, Anran Chen, Jianheng Peng +20 more

Normal breast tissues harbour rare populations of aneuploid epithelial cells

Nature(2024)10.1038/s41586-024-08129-x

N/A

0DataRank · unranked

35 citations

Junke Wang, Kaile Wang, Shanshan Bai, Aatish Thennavan, Runmin Wei +16 more

Additional expression of T-cell engager in clinically tested oncolytic adeno-immunotherapy redirects tumor-infiltrated, irrelevant T cells against cancer cells to enhance antitumor immunity

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009741

N/A

0DataRank · unranked

7 citations

Amanda Rosewell Shaw, Greyson Biegert, Caroline E. Porter, Mae Woods, Spyridoula Vasileiou +3 more

Bone-Induced HER2 Promotes Secondary Metastasis in HR+/HER2− Breast Cancer

Cancer Discovery(2025)10.1158/2159-8290.cd-23-0543

N/A

0DataRank · unranked

5 citations

Anna Reva, David G. Edwards, Bree M. Lege, Laura Muñoz-Arcos, Carolina Reduzzi +22 more

Inhibition of MCL-1 and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers

Molecular Cancer Therapeutics(2025)10.1158/1535-7163.mct-24-0593

N/A

0DataRank · unranked

2 citations

Moises Tacam, Alex W. Tan, Mary Kathryn Pitner, LaKesla R. Iles, Xiaoding Hu +16 more

Resolving clonal substructure from single cell genomic data using CopyKit

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.09.483497

N/A

0DataRank · unranked

13 citations

Emi Sei, Junke Wang, Aislyn Schalck, Yun Yan, Alexander Davis +14 more

Lung mesenchymal cells elicit lipid storage in neutrophils that fuel breast cancer lung metastasis

Nature Immunology(2020)10.1038/s41590-020-0783-5

N/A

0DataRank · unranked

247 citations

Ming Lü, Jiayuan Shi, Zheng Gong, Li Hua, Qing Li +7 more

Online Couple-Based Meditation Intervention for Patients With Primary or Metastatic Brain Tumors and Their Partners: Results of a Pilot Randomized Controlled Trial

Journal of Pain and Symptom Management(2020)10.1016/j.jpainsymman.2020.02.004

N/A

0DataRank · unranked

71 citations

Shiao‐Pei Weathers, Sania Durrani, Yisheng Li, Meagan Whisenant, Jing Li +6 more

Targeting Signaling Pathways in Inflammatory Breast Cancer

Cancers(2020)10.3390/cancers12092479

N/A

0DataRank · unranked

40 citations

Takashi Semba, Lan Thi Phi, Sudpreeda Chainitikun, Toshiaki Iwase, Bora Lim +2 more

A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer

Investigational New Drugs(2020)10.1007/s10637-020-00995-2

N/A

0DataRank · unranked

28 citations

Gaiane M. Rauch, Tanbin Rahman, Meghan Karuturi, Elizabeth E. Ravenberg, Jason B. White +14 more

First-in-Human Phase 1b Trial of Quinacrine Plus Capecitabine in Patients With Refractory Metastatic Colorectal Cancer

Clinical Colorectal Cancer(2020)10.1016/j.clcc.2020.08.003

N/A

0DataRank · unranked

6 citations

Crystal S. Denlinger, Namrata Vijayvergia, Steven J. Cohen, Igor Astaturov, Efrat Dotan +14 more

High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types

Annals of Oncology(2021)10.1016/j.annonc.2021.02.006

N/A

0DataRank · unranked

1067 citations

P.G. Pilié, N.U. Rashid, Leonie Voorwerk, Maarten Slagter, Marleen Kok +11 more

A phase II study of talimogene laherparepvec for patients with inoperable locoregional recurrence of breast cancer

Scientific Reports(2021)10.1038/s41598-021-01473-2

N/A

0DataRank · unranked

23 citations

Angela Marx, Diane D. Liu, Yu Shen, Hui Gao, James M. Reuben +9 more

PI3K and MAPK Pathways as Targets for Combination with the Pan-HER Irreversible Inhibitor Neratinib in HER2-Positive Breast Cancer and TNBC by Kinome RNAi Screening

Biomedicines(2021)10.3390/biomedicines9070740

N/A

0DataRank · unranked

19 citations

Huey Liu, Troy Pearson, Toshiaki Iwase, Jon A. Fuson, Alshad S. Lalani +6 more

Bora Lim

Indexed papers

Top data-sharing exemplar

Papers